2018, Number S1
Rev Mex Anest 2018; 41 (S1)
Ketamine: an adjuvant in the treatment of pain that is difficult to control
Cáñez-Jiménez C, González-López N, Ramírez-Segura EH
Language: Spanish
References: 6
Page: 153-154
PDF size: 143.50 Kb.
Text Extraction
No abstract.
REFERENCES
Jonkman K, Dahan A, van de Donk T, Aarts L, Niesters M, van Velzen M. Ketamine for pain. F1000Res. 2017;6.
Merskey H, Bogduk N. Task force on taxonomy part III: pain terms, a current list with definitions and notes on usage. IASP Task Force Taxon 1994: 209-214. Disponible: http://www.iasp-pain.org/Content/NavigationMenu/GeneralResourceLinks/PainDefinitions/default.htm#Pain
Goel AP, Maher DP, Cohen SP. Ketamine: miracle drug or latest fad? Pain Manag. 2017. doi: 10.2217/pmt-2017-0022. [Epub ahead of print]
Peltoniemi MA, Hagelberg NM, Olkkola KT, Saari TI. C Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. lin Pharmacokinet. 2016;55:1059-1077.
Michelet D, Brasher C, Horlin AL, Bellon M, Julien-Marsollier F, Vacher T, et al. Ketamine for chronic non-cancer pain: A meta-analysis and trial sequential analysis of randomized controlled trials. Eur J Pain. 2018;22:632-646.
Bell RF, Eccleston C, Kalso EA. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev. 2017;6:CD003351.
Full text